earnings
confidence high
sentiment negative
materiality 0.75
Aptar Q4 net income down 26%, adjusted EPS $1.25 vs $1.62; new $600M buyback
APTARGROUP, INC.
2025-FY EPS
reported $5.89
vs consensus $1.24
▲ beat
(+374.7%)
- Reported sales +14% to $963M (core +5%); net income -26% to $74M ($1.13 EPS).
- Adjusted EPS $1.25 vs $1.62; adjusted EBITDA margin 19.8% vs 23.0%.
- Pharma core sales +4% (injectables +24%), Beauty +10%, Closures +1%.
- Board authorized new $600M share repurchase; Q1 2026 adjusted EPS guidance $1.13-$1.21.
- Returned $206M to shareholders in Q4 via buybacks and dividends; quarterly dividend $0.48.